X4 PHARMACEUTICALS INC
COM · CUSIP 98420X103
1
institutional holders
-1 vs Q1 2026
3.2m
shares reported held*
$15.1mreported value*
0 new
0 added
0 reduced
1 sold out
net sold ≈ $1.1m (-234.0k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $4.67.
Trends to Q2 2026
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 60 |
| Q4 2022 | 54 |
| Q1 2023 | 61 |
| Q2 2023 | 97 |
| Q3 2023 | 92 |
| Q4 2023 | 94 |
| Q1 2024 | 99 |
| Q2 2024 | 101 |
| Q3 2024 | 99 |
| Q4 2024 | 91 |
| Q1 2025 | 93 |
| Q2 2025 | 2 |
| Q3 2025 | 2 |
| Q4 2025 | 3 |
| Q1 2026 | 2 |
| Q2 2026 | 1 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2024 | 44 | 31 |
| Q4 2024 | 35 | 42 |
| Q1 2025 | 41 | 34 |
| Q2 2025 | 0 | 92 |
| Q3 2025 | 2 | 0 |
| Q4 2025 | 2 | 0 |
| Q1 2026 | 0 | 2 |
| Q2 2026 | 0 | 1 |
Biggest buyers
| None |
Biggest sellers
| ACORN CAPITAL ADVISORS, LLC | Sold out | -234.0k |
Holders, Q2 2026
| Manager | Shares | Change |
|---|---|---|
| NEA Management Company, LLC 0.95% of their portfolio | 3.2m $15.1m | Unchanged |